Case Series of Men with the Germline APCI1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer

MLA

Economides, Minas P., et al. “Case Series of Men with the Germline APCI1307K Variant and Treatment-Emergent Neuroendocrine Prostate Cancer.” Clinical Genitourinary Cancer, vol. 22, no. 1, Feb. 2024, p. e31–e37.e1. EBSCOhost, https://doi.org/10.1016/j.clgc.2023.06.013.

APA

Economides, M. P., Nakazawa, M., Lee, J. W., Li, X., Hollifield, L., Chambers, R., Sarfaty, M., Goldberg, J. D., Antonarakis, E. S., & Wise, D. R. (2024). Case Series of Men with the Germline APCI1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer. Clinical Genitourinary Cancer, 22(1), e31–e37.e1. https://doi.org/10.1016/j.clgc.2023.06.013

Chicago

Economides, Minas P., Mari Nakazawa, Jonathan W. Lee, Xiaochun Li, Lucas Hollifield, Rachelle Chambers, Michal Sarfaty, Judith D. Goldberg, Emmanuel S. Antonarakis, and David R. Wise. 2024. “Case Series of Men with the Germline APCI1307K Variant and Treatment-Emergent Neuroendocrine Prostate Cancer.” Clinical Genitourinary Cancer 22 (1): e31–e37.e1. doi:10.1016/j.clgc.2023.06.013.